定点医药机构采集药品追溯码 已破千亿条

Core Viewpoint - The article highlights the importance of drug traceability codes as unique identifiers for pharmaceuticals, which are crucial in combating counterfeit and diverted drugs. The National Healthcare Security Administration (NHSA) has reported significant progress in the collection of these codes, with a mandate for full compliance by 2026 [1] Group 1: Drug Traceability Codes - Drug traceability codes serve as "electronic IDs" for each box of medication, playing a vital role in ensuring drug safety and authenticity [1] - As of now, approximately 440.8 billion drug traceability codes have been collected from the production and distribution sectors, while 1,014.81 billion codes have been collected from designated medical institutions [1] - There are three common types of drug traceability codes in China: the "Code on Assurance" 20-digit barcode, company-specific codes, and the international GS1 coding system, which is often used for imported drugs [1] Group 2: Future Compliance and Consumer Access - Starting January 1, 2026, all medical institutions in China are required to fully collect and upload drug traceability codes [1] - Consumers can access detailed sales information of drugs by scanning the traceability code on the packaging through the NHSA's WeChat public account [1] - The GS1 system has been adopted by over 150 countries and regions, with 116 coding organizations participating globally [1]